Page last updated: 2024-12-07

cholesterol 7-hydroperoxide

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

cholesterol 7-hydroperoxide: RN given refers to (3beta,7alpha)-isomer; structure given in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID114774
SCHEMBL ID7138643
MeSH IDM0121803

Synonyms (14)

Synonym
3beta-hydroxycholest-5-ene-7alpha-hydroperoxide
cholest-5-en-3-ol, 7-hydroperoxy-, (3-beta,7-alpha)-
3-beta-hydroxycholest-5-ene-7-alpha-hydroperoxide
ccris 2346
cholesterol 7-hydroperoxide
cholesterol 7-alpha-hydroperoxide
2846-29-9
(3s,7s,8s,9s,10r,13r,14s,17r)-7-hydroperoxy-10,13-dimethyl-17-[(2r)-6-methylheptan-2-yl]-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1h-cyclopenta[a]phenanthren-3-ol
SCHEMBL7138643
7-hydroperoxycholesterol
7-hydroperoxycholest-5-en-3beta-ol
7alpha-hydroperoxycholesterol
DTXSID20951106
7-hydroperoxycholest-5-en-3-ol

Research Excerpts

Dosage Studied

ExcerptRelevanceReference
"Sterol hydroperoxides 3 beta-hydroxy-5 alpha-cholest-6-ene-5-hydroperoxide and 3 beta-hydroxycholest-5-ene-7 alpha-hydroperoxide show weak dose-response direct mutagenicity towards Salmonella typhimurium strain TA 1537 in a liquid medium incubation bioassay."( Mutagenic sterol hydroperoxides.
Made Gowda, N; Smart, VB; Smith, LL, 1986
)
0.27
"In order to rationalize multiphasic dose-response data evincing mutagenicity towards Salmonella typhimurium TA1537 for sterol hydroperoxides 3 beta-hydroxy-5 alpha-cholest-6-ene-5-hydroperoxide and 3 beta-hydroxycholest-5-ene-7 alpha-hydroperoxide their metabolism by the bacterial test strain was investigated."( Sterol hydroperoxide metabolism by Salmonella typhimurium.
Made Gowda, NM; Smith, LL; Teng, JI, 1987
)
0.27
" In contrast, cholesterol-derived hydroperoxides were not affected in lung of paraquat dosed rats."( 7-Hydroperoxycholesterol as a marker of oxidative stress in rat kidney induced by paraquat.
Adachi, J; Asano, M; Naito, T; Tomita, M; Ueno, Y; Yamakawa, S, 2000
)
0.31
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (34)

TimeframeStudies, This Drug (%)All Drugs %
pre-19903 (8.82)18.7374
1990's15 (44.12)18.2507
2000's10 (29.41)29.6817
2010's6 (17.65)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 11.42

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index11.42 (24.57)
Research Supply Index3.56 (2.92)
Research Growth Index4.97 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (11.42)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews1 (2.94%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other33 (97.06%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]